Phase
Condition
Leukemia
Acute Myeloid Leukemia
Platelet Disorders
Treatment
ChromoSeq
Clinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria Patient
Patient with a clinical suspicion for a new diagnosis of AML or MDS for whom the diagnostic molecular testing via the hematologic molecular algorithm (HMA) at BJH is requested or planned to be requested.
Adult patients 18 years or older.
Ability to understand and willingness to sign an IRB approved written informed consent document.
Inclusion Criteria Physician
Treating physician at Washington University School of Medicine who directs therapy for individuals with hematologic malignancies.
Able and willing to complete standardized questionnaires about usability, and stakeholder perceptions of ChromoSeq during the ChromoSeq implementation process.
Exclusion Criteria Patient
- Younger than 18 years of age
Exclusion Criteria Physician
- Does not treat patients at Washington University School of Medicine
Study Design
Connect with a study center
Washington University School of Medicine
Saint Louis, Missouri 63110
United StatesSite Not Available
Washington University School of Medicine
St Louis 4407066, Missouri 4398678 63110
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.